Emergence of the Asian 1 genotype of dengue Virus serotype 2 in viet Nam: in vivo fitness advantage and lineage replacement in South-East Asia

PLoS Neglected Tropical Diseases

Volumn 4, Issue 7, 2010, Pages

  Hang, Vu Thi Ty ^a   Holmes, Edward C ^b,c   Veasna, Duong ^d   Quy, Nguyen Thien ^a   Hien, Tran Tinh ^e   Quail, Michael ^f   Churcher, Carol ^f   Parkhill, Julian ^f   Cardosa, Jane ^g   Farrar, Jeremy ^a   Wills, Bridget ^a   Lennon, Niall J ^h   Birren, Bruce W ^h   Buchy, Philippe ^d   Henn, Matthew R ^h   Simmons, Cameron P ^a  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g Sarawak   (Malaysia)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AEDES AEGYPTI; ANIMAL CELL; ARTICLE; ASIA; CAMBODIA; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VIVO STUDY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; MOSQUITO; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PRESCHOOL CHILD; PROBABILITY; SCHOOL CHILD; SEROTYPING; THAILAND; VIET NAM; VIREMIA; VIRUS TRANSMISSION;

EID: 78149255559     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000757     Document Type: Article

References (26)

1. Paediatric Dengue Vaccine Initiative (2009) Global burden of Dengue.
2. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, et al. (2003) Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191-202.
3. Twiddy SS, Pybus OG, Holmes EC (2003) Comparative population dynamics of mosquito-borne flaviviruses. Infect Genet Evol 3: 87-95.
4. Sittisombut N, Sistayanarain A, Cardosa MJ, Salminen M, Damrongdachakul S, et al. (1997) Possible occurrence of a genetic bottleneck in dengue serotype 2 viruses between the 1980 and 1987 epidemic seasons in Bangkok, Thailand. Am J Trop Med Hyg 57: 100-108.
5. Wittke V, Robb TE, Thu HM, Nisalak A, Nimmannitya S, et al. (2002) Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology 301: 148-156.
6. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM (2003) Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 9: 800-809.
7. Myat Thu H, Lowry K, Jiang L, Hlaing T, Holmes EC, et al. (2005) Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection. Virology 336: 163-172.
8. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, et al. (1997) Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230: 244-251.
9. Bennett SN, Holmes EC, Chirivella M, Rodriguez DM, Beltran M, et al. (2006) Molecular evolution of dengue 2 virus in Puerto Rico: positive selection in the viral envelope accompanies clade reintroduction. J Gen Virol 87: 885-893.
10. Gubler DJ, Reed D, Rosen L, Hitchcock JR, Jr. (1978) Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 27: 581-589.
11. Gubler DJ, Suharyono W, Lubis I, Eram S, Gunarso S (1981) Epidemic dengue 3 in central Java, associated with low viremia in man. Am J Trop Med Hyg 30: 1094-1099.
12. Hang VT, Nguyet NM, Trung DT, Tricou V, Yoksan S, et al. (2009) Diagnostic Accuracy of NS1 ELISA and Lateral Flow Rapid Tests for Dengue Sensitivity, Specificity and Relationship to Viraemia and Antibody Responses. PLoS Negl Trop Dis 3: e360.
13. Simmons CP, Popper S, Dolocek C, Chau TN, Griffiths M, et al. (2007) Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 195: 1097-1107.
14. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
15. Swofford DL (2003) PAUP*.Phylogenetic Analysis Using Parsimony (*and other methods). Version 4. ed: Sinauer Associates. Sunderland, Mass.
16. Zwickl DJ (2006) Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. Austin: The University of Texas at Austin.
17. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
18. Mathew A, Rothman AL (2008) Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 225: 300-313.
19. Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100: 6986-6991.
20. Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinoza A, et al. (2002) Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360: 310-312.
21. Armstrong PM, Rico-Hesse R (2001) Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis 1: 159-168.
22. Armstrong PM, Rico-Hesse R (2003) Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am J Trop Med Hyg 68: 539-544.
23. Cologna R, Armstrong PM, Rico-Hesse R (2005) Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol 79: 853-859.
24. Recker M, Blyuss KB, Simmons CP, Hien TT, Wills B, et al. (2009) Immunological serotype interactions and their effect on the epidemiological pattern of dengue. Proc Biol Sci 276: 2541-2548.
25. Whitehead SS, Blaney JE, Durbin AP, Murphy BR (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol 5: 518-528.
26. Keller TH, Chen YL, Knox JE, Lim SP, Ma NL, et al. (2006) Finding new medicines for flaviviral targets. Novartis Found Symp 277: 102-114; discussion 114-109, 251-103.